Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Methotrexate
•
Hepatology
Is there a role for the use of transient elastography (FibroScan) to monitor liver fibrosis in patients on long term methotrexate?
Answer from: at Community Practice
No
Sign in or Register to read more
14210
Related Questions
Do you avoid JAK inhibitors in patients with a history of liver disease including NAFLD or cirrhosis?
How do you approach an obese patient on long-term methotrexate with normal liver tests in terms of workup for underlying fatty liver?
How do you approach methotrexate management around vaccines other than COVID and influenza?
How often do you monitor labs in patients taking methotrexate?
Do you combine methotrexate and leflunomide for the treatment of RA?
Do you consider Anti-carbamylated protein antibodies (anti-CarP) as having any significance in evaluation of patients if RF and ACPA negative and clinically no active synovitis yet widespread arthralgias and generalized osteoarthritis?
Do you offer LDRT for psoriatic arthritis, rheumatoid arthritis, or polymyalgia rheumatica or fibromyalgia?
In an RA patient with positive RF and CCP abs who is stable on TNFi biologic, how would you approach incidentally found low titer positive DsDNA abs?
Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?
What is your approach for managing DMARDs in patients with rheumatoid arthritis and newly diagnosed HIV?